Intensity modulated radiotherapy (IMRT) can reduce the dose to surrounding organs and healthy tissue for non–small cell lung cancer (NCSLC) patients beyond what is achievable with conventional radiotherapy. We report favourable toxicity outcomes including
- Journal of Medical Radiation Sciences 2016
- 63:3